Read + Share
Amedeo Smart
Independent Medical Education
Hendrikse CSE, Theelen PMM, van der Ploeg P, Westgeest HM, et al. The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis. Gynecol Oncol 2023;171:83-94.PMID: 36841040
Email
LinkedIn
Facebook
Twitter
Privacy Policy